Free tool
Oncology stocks
We cover 1 company grouped under the Oncology theme. The median market value in the group is $25.70M. Across the group, the median move over the past trading day is −1.37%. Price change over the past year runs from −73.3% to −73.3% across the middle 80 percent of the group, with a median of −73.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 319 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| IMU.AX | Imugene Limited | $25.70M | Micro cap | −73.33% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.